CSTL - Castle Biosciences outlines $33B AdvanceAD-Tx market opportunity while raising 2025 revenue guidance
2025-11-03 23:07:07 ET
More on Castle Biosciences
- Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call Transcript
- Castle Biosciences: Strong Margins, Solid Balance Sheet, And Big Upside Potential
- Seeking Alpha’s Quant Rating on Castle Biosciences
- Historical earnings data for Castle Biosciences
- Financial information for Castle Biosciences